These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 34902958)
1. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers. Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. Yang SR; Gedvilaite E; Ptashkin R; Chang J; Ziegler J; Mata DA; Villafania LB; Nafa K; Hechtman JF; Benayed R; Zehir A; Benhamida J; Arcila ME; Mandelker D; Rudin CM; Paik PK; Drilon A; Schoenfeld AJ; Ladanyi M J Thorac Oncol; 2024 Mar; 19(3):409-424. PubMed ID: 37838086 [TBL] [Abstract][Full Text] [Related]
4. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435 [TBL] [Abstract][Full Text] [Related]
5. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis. Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091 [TBL] [Abstract][Full Text] [Related]
6. High homogeneity of MMR deficiency in ovarian cancer. Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330 [TBL] [Abstract][Full Text] [Related]
7. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078 [TBL] [Abstract][Full Text] [Related]
8. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors. Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India. Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922 [TBL] [Abstract][Full Text] [Related]
10. Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in Uterine Endometrioid Carcinoma. Adachi S; Kimata JI; Hanami K; Adachi K; Igarashi T; Liang SG; Ishida Y; Fujino T; Yamazaki K Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):24-31. PubMed ID: 37859432 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters. Hashmi AA; Mudassir G; Hashmi RN; Irfan M; Asif H; Khan EY; Abu Bakar SM; Faridi N Asian Pac J Cancer Prev; 2019 Sep; 20(9):2601-2606. PubMed ID: 31554352 [TBL] [Abstract][Full Text] [Related]
12. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970 [TBL] [Abstract][Full Text] [Related]
13. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123 [TBL] [Abstract][Full Text] [Related]
15. An exploration of gastric cancer with heterogeneous mismatch repair status. Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896 [TBL] [Abstract][Full Text] [Related]
16. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial. Smyth EC; Wotherspoon A; Peckitt C; Gonzalez D; Hulkki-Wilson S; Eltahir Z; Fassan M; Rugge M; Valeri N; Okines A; Hewish M; Allum W; Stenning S; Nankivell M; Langley R; Cunningham D JAMA Oncol; 2017 Sep; 3(9):1197-1203. PubMed ID: 28241187 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status. Sugimoto R; Endo M; Osakabe M; Toya Y; Yanagawa N; Matsumoto T; Sugai T Digestion; 2021; 102(5):691-700. PubMed ID: 33053554 [TBL] [Abstract][Full Text] [Related]
18. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112 [TBL] [Abstract][Full Text] [Related]
19. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997 [No Abstract] [Full Text] [Related]
20. Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome. Liu YL; Cadoo KA; Maio A; Patel Z; Kemel Y; Salo-Mullen E; Catchings A; Ranganathan M; Kane S; Soslow R; Ceyhan-Birsoy O; Mandelker D; Carlo MI; Walsh MF; Shia J; Markowitz AJ; Offit K; Stadler ZK; Latham A Genet Med; 2022 Jun; 24(6):1187-1195. PubMed ID: 35346574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]